医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Aderans Completes Acquisition of Hair Club, Expands Services in US Hair Replacement Market

2013年04月10日 AM08:25
このエントリーをはてなブックマークに追加


 

TOKYO & BEVERLY HILLS, Calif.

Aderans Co, Ltd. (“Aderans”)(T.8170) announced today that it completed the acquisition of Hair Club, a leader in the North American hair replacement services market, for $163.5 million.

“We are pleased to complete the acquisition of Hair Club and warmly welcome Hair Club customers, employees and franchisees to the Aderans group,” said Nobuo Nemoto, founder and representative director of Aderans. “Aderans continues to focus on profitable ways to grow revenues across the globe.”

Headquartered in Tokyo, Japan, Aderans is a global provider of hair replacement and restoration products and services, owning internationally-recognized brands ADERANS for men and women, FONTAINE for women, BOSLEY, a provider of hair loss solutions and medical hair restoration and now HAIR CLUB, the leading North American “all proven solutions provider” of hair restoration services for men and women.

“The acquisition of Hair Club significantly grows Aderans’ North American revenues. By bringing together Bosley and Hair Club, Aderans now has the largest network of surgical and non-surgical hair restoration services in North America,” said Joshua Schechter, Chairman of Aderans America Holdings, Inc. “We will now focus on combining the best practices of Bosley, Hair Club and Aderans in order to provide the best experience and results for our customers.”

About Aderans:

Founded in 1969, Aderans is a global provider of hair replacement and restoration products and services, whose internationally-recognized brands include ADERANS custom-made wigs, hair products and services for men, FONTAINE custom-made and ready-to-wear wigs, products and services for women, BOSLEY, providing hair loss solutions and medical hair restoration and HAIR CLUB, the leading all proven solutions provider of hair restoration services for men and women.

CONTACT

Sitrick And Company
Jason Booth, 1-310-788-2850
Jason_Booth@Sitrick.com

同じカテゴリーの記事 

  • 画期的な報告書により、高いニコチン消費量は健康問題の発生率を高めないことが証明される
  • 基于LC-Plasma的疫苗研究入选SCARDA项目
  • LC-Plasma-based Vaccine Research Selected for SCARDA Project
  • 一份具有里程碑意义的报告证明,大量使用尼古丁不会导致健康问题高发
  • Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)